Curiox Biosystems, a leader in automated systems for flow cytometry sample preparation, announced today that it has expanded its leadership team by appointing David Choiniere as Vice President, Sales and Marketing for North America.
Presented by Dr. Prabhakar Putheti, MS, PhD. Dr. Prabhakar shares his experiences using the DA-Cell™ Washing System to save time with automated washing in his transplantation lab.
Lysing and washing red blood cells using traditional microtiter plates or tubes may result in significant cell loss and damage. There is now a better way to lyse RBCs while achieving clean antibody staining and lysis as good as or …
Results from a December 2017 survey of 68 flow cytometry users and managers in pharma and biotech. Flow cytometrists were also asked about a new product from Curiox that washes cells without centrifugation. How do you compare to your peers?
Curiox Biosystems was proud to have been chosen as a finalist in the CYTO Innovation 2017 Technology Showcase at the 32nd Congress of the International Society for the Advancement of Cytometry meeting in June, 2017. Dr. Namyong Kim introduced the new DA-Cell™ technology, a revolutionary centrifuge-less cell processing system for the flow cytometry market.
Multiplexed bead assays have always been prone to aggregation, especially in the presence of complex biological fluids and matrices. The inherent properties of magnetic beads in regards to size, magnetism, and coatings (both polymer and conjugated protein) can lead the magnetic particles to clump or aggregate during the assay incubations, washings, and resuspensions.
Curiox Biosystems is proud to announce the addition of three new distributors in Europe for the DropArray™ System. The three distributors include Cambridge Bioscience covering the United Kingdom, CliniSciences servicing France and THP Biomedical supplying Austria, Czech Republic, Slovakia, Hungary, and Slovenia.
The journey from researchlab to selling an innovation is often long and unpredictable. Rennie Whang speaks to Dr Namyong Kim, chief executive of A*Star spin-off Curiox Biosystems, about the ups and downs it encountered.